Skip to main content

Month: March 2026

Bridger Aerospace Names Justin Mogford as General Counsel, Further Strengthening Management Team

BELGRADE, Mont., March 26, 2026 (GLOBE NEWSWIRE) — Bridger Aerospace Group Holdings, Inc. (“Bridger” or the “Company”) (NASDAQ: BAER. BAERW), one of the nation’s leading aerial firefighting companies, today announced the appointment of Justin Mogford as General Counsel and Corporate Secretary, effective in April. Mr. Mogford will replace James Muchmore, who is stepping down. Mogford will lead the Company’s legal, compliance, and governance functions as Bridger scales its operations and strengthens its leadership. Mogford is a seasoned public company corporate attorney, having spent more than a decade at Bristow Group Inc. (NASDAQ: VTOL), a provider of helicopter offshore energy transportation and search and rescue services to civil and government organizations worldwide, where he served most recently as Division General Counsel, Advanced...

Continue reading

Abaxx Announces Fourth Quarter and Year-End 2025 Earnings and Business Update Call

TORONTO, March 26, 2026 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), today announced that it will host a webcast to discuss its fourth quarter and year-end 2025 financial results and provide an update on the Company’s business and market development on Thursday, April 2nd at 10:00 a.m. EDT. The Company expects to release its financial results after market close on March 31, 2026. The webcast will begin at 10:00 a.m. EDT, during which Abaxx management will provide prepared remarks followed by a question-and-answer session. Interested participants can register for the...

Continue reading

RVYL Shareholder Meeting Continued to April 1, with 99% of Votes Cast in Favor of Roundtable Merger

Just 5% Additional Vote Needed to Reach >50% “Yes-Quorum,” to Complete Merger with Roundtable, Inc. SAN DIEGO, CA, March 26, 2026 (GLOBE NEWSWIRE) — RYVYL Inc. (NASDAQ: RVYL) today announced that, at its Special Meeting of Shareholders to vote on the Company’s planned merger with RTB Digital, Inc. (“Roundtable”), 99% of votes cast continue to support the merger, with 659,620 votes in favor collected to date. Approval by holders of >50% of outstanding shares is required to consummate the merger, meaning only an additional 5% is needed to complete the process. The Company’s board of directors, in consultation with its proxy solicitors, has decided to further adjourn the meeting to allow additional time for vote collection and will reconvene virtually on April 1, 2026 at 4:00 p.m. EST. The record date of February 6, 2026 remains unchanged...

Continue reading

SPIE announces the winners of Innovation Day 2026

Winners of Innovation Day 2026Winners of Innovation Day 2026Innovation Day 2026Innovation Day 2026Cergy, 26 March 2026 – The SPIE Group, the independent European leader in multi-technical services in the areas of energy and communications, has announced the winners of the 2026 Innovation Day. Held every two years, this event brings together employees and partners to showcase the most innovative solutions developed across the Group’s various subsidiaries. The 2026 edition, held on 25 March 2026 in Düsseldorf, Germany, brought together more than 600 participants and featured more than 100 innovations. Innovation Day is a key event in SPIE’s innovation strategy. It provides an opportunity to share solutions developed by the teams and to highlight the Group’s innovation priorities, which deliver practical responses to client...

Continue reading

Cielo Provides Update on Proposed Acquisition and Announces Investor Summit Presentation

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, March 26, 2026 (GLOBE NEWSWIRE) — Cielo Waste Solutions Corp. (TSXV: CMC; OTCQB: CWSFF) (“Cielo” or the “Company”) is pleased to provide an update to its previously announced binding letter of intent dated February 9, 2026 (the “LOI”) with Canadian Discovery Ltd. (“CDL”), as previously announced on February 10, 2026, in respect of Cielo’s proposed acquisition (the “Proposed Acquisition”) of certain proprietary project development and evaluation assets (the “Assets”). The Company has entered into an amendment to the LOI dated March 25, 2026 (the “Amendment”). The Company is also pleased to announce that its Chief Executive Officer, Ryan C. Jackson, will participate in a webcast presentation...

Continue reading

Hyperion DeFi Reports 4Q and FY 2025 Financial Results with Quarter-over-Quarter Growth of +64% Revenue and +87% Adjusted Gross Profit

Five Diversified, Ramping DeFi Business Lines Delivered Growth Exceeding Q4 Guidance Treasury Exceeds 1.93M HYPE, 1.92M KNTQ, & 1.00M HPL Tokens as of March 23(14) HYPD’s Unique “Triple-Dip” HYPE Deployment Generated ~3x Base Staking Income in Q4 Announces Executed LOI to Monetize the Optejet, With Potential Closing in Q2’26 LAGUNA HILLS, Calif., March 26, 2026 (GLOBE NEWSWIRE) — Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed DeFi company building on Hyperliquid, today reported results for the fourth quarter and full year ending December 31, 2025. “Against a backdrop of significant market volatility, we are pleased to report rapid growth in our DeFi operating businesses which exceeded our guidance in the fourth quarter,” said Hyunsu Jung, CEO of Hyperion DeFi. Mr. Jung...

Continue reading

MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Phase 2 ZEPHYR trial of ML-007C-MA for schizophrenia expected to reach target enrollment (n=300) in April 2026, with topline results expected in the third quarter of 2026 Phase 2 IRIS trial for ML-004 for autism spectrum disorder has completed enrollment, with topline results expected in the third quarter of 2026 Received FDA Fast Track designation for ML-007C-MA for Alzheimer’s disease psychosis; topline results from Phase 2 VISTA trial expected in the second half of 2027 Expanded pipeline with a next-generation M1/M4 muscarinic agonist program, ML-055, with candidate nomination expected in 2026 Ended the year with $453.1 million in cash, cash equivalents and investments, which is expected to fund operations through 2027SAN FRANCISCO and BOSTON, March 26, 2026 (GLOBE NEWSWIRE) — MapLight Therapeutics, Inc. (Nasdaq: MPLT), a...

Continue reading

Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights

Expect to report topline results for ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, in late 2026 Lead clinical candidate IND filing in Acumen’s Enhanced Brain Delivery (EBDTM) program targeted for mid-2027, following strong preclinical data and $35.75 million private placement to advance candidates in AβO-selective EBD portfolio Cash, cash equivalents and marketable securities of $116.9 million as of Dec. 31, 2025, expected to support current clinical and operational activities into early 2027  Company to host conference call and webcast today at 8:00 a.m. ET NEWTON, Mass., March 26, 2026 (GLOBE NEWSWIRE) —  Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target...

Continue reading

Verde AgriTech Announces Q4 & FY 2025 Earnings Results

All figures are in Canadian dollars unless otherwise stated. BELO HORIZONTE, Brazil and SINGAPORE, March 26, 2026 (GLOBE NEWSWIRE) — Verde AgriTech Ltd (TSX: NPK | OTCQX: VNPKF) (“Verde” or the “Company”), today reported its operating and financial results for the fourth quarter and fiscal year ended December 31, 2025 (“Q4 2025” and “FY 2025”). “The Great Brazilian Agriculture Crisis continued to weigh on sales throughout 2025, and the sharp rise in judicial recovery filings across Brazil’s agribusiness sector shows how stressed the market remains. Since the crisis began in 2023, Verde has maintained a highly restrictive credit approval policy, prioritizing receivables quality, liquidity preservation and commercial discipline over volume at any cost. We believe this has been the right approach to protect the Company and preserve...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.